Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Witzig

Showing results (11-20 of 183) with videos related to

Pageof 19
Sort By:
Archives of Internal Medicine|December 1, 2001
Complete resolution of reflex sympathetic dystrophy with thalidomide treatmentS V Rajkumar, R Fonseca, T E Witzig
American Journal of Hematology|November 1, 1985
Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1)P R Greipp, T E Witzig, N J Gonchoroff
American Journal of Otolaryngology|January 1, 1991
Lymphoproliferative disorders of the head and neckJ D Green, H B Neel, T E Witzig
Current Topics in Microbiology and Immunology|January 1, 1992
Circulating peripheral blood plasma cells in multiple myelomaT E Witzig, R A Kyle, P R Greipp
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growthD F Jelinek, T E Witzig, B K Arendt
Leukemia & Lymphoma|August 28, 1998
Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemiaT E Witzig, T Kimlinger, M Stenson, et al.
The New England Journal of Medicine|September 30, 2000
Life-threatening toxic epidermal necrolysis with thalidomide therapy for myelomaS V Rajkumar, M A Gertz, T E Witzig
Current Topics in Microbiology and Immunology|January 1, 1995
Detection of peripheral blood myeloma cells by three-color flow cytometryT E Witzig, T K Kimlinger, P R Greipp
Leukemia & Lymphoma|June 1, 1994
Effects of phenylacetate on cells from patients with B-chronic lymphocytic leukemiaT G Call, M J Stenson, T E Witzig
Obstetrics and Gynecology|October 1, 1994
Giant uterine fibromyoma producing secondary polycythemiaC L Clark, T O Wilson, T E Witzig
Pageof 19

Showing results (11-20 of 183) with videos related to

Sort By:
Pageof 19
Archives of Internal Medicine|December 1, 2001
Complete resolution of reflex sympathetic dystrophy with thalidomide treatmentS V Rajkumar, R Fonseca, T E Witzig
American Journal of Hematology|November 1, 1985
Immunofluorescent plasma cell labeling indices (LI) using a monoclonal antibody (BU-1)P R Greipp, T E Witzig, N J Gonchoroff
American Journal of Otolaryngology|January 1, 1991
Lymphoproliferative disorders of the head and neckJ D Green, H B Neel, T E Witzig
Current Topics in Microbiology and Immunology|January 1, 1992
Circulating peripheral blood plasma cells in multiple myelomaT E Witzig, R A Kyle, P R Greipp
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1997
A role for insulin-like growth factor in the regulation of IL-6-responsive human myeloma cell line growthD F Jelinek, T E Witzig, B K Arendt
Leukemia & Lymphoma|August 28, 1998
Syndecan-1 expression on malignant cells from the blood and marrow of patients with plasma cell proliferative disorders and B-cell chronic lymphocytic leukemiaT E Witzig, T Kimlinger, M Stenson, et al.
The New England Journal of Medicine|September 30, 2000
Life-threatening toxic epidermal necrolysis with thalidomide therapy for myelomaS V Rajkumar, M A Gertz, T E Witzig
Current Topics in Microbiology and Immunology|January 1, 1995
Detection of peripheral blood myeloma cells by three-color flow cytometryT E Witzig, T K Kimlinger, P R Greipp
Leukemia & Lymphoma|June 1, 1994
Effects of phenylacetate on cells from patients with B-chronic lymphocytic leukemiaT G Call, M J Stenson, T E Witzig
Obstetrics and Gynecology|October 1, 1994
Giant uterine fibromyoma producing secondary polycythemiaC L Clark, T O Wilson, T E Witzig
Pageof 19